Report cover image

Sumitomo Pharma Co., Ltd. - Company Profile and SWOT Analysis

Publisher MarketLine
Published Dec 22, 2025
Length 44 Pages
SKU # MTLN20809404

Description

Sumitomo Pharma Co., Ltd. - Company Profile and SWOT Analysis

Summary

Sumitomo Pharma Co., Ltd. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sumitomo Pharma Co., Ltd. (SPL or 'the company'), a subsidiary of Sumitomo Chemical Co Ltd, is a developer, manufacturer, and importer of pharmaceutical products. The company focuses on major therapeutic areas which include cardiovascular, central nervous system (CNS), diabetes, respiratory psychiatry, oncology and neurology diseases. It also markets food ingredients, food additives, chemical product materials, veterinary drugs, diagnostics, and other products. SPL also owns and operates manufacturing and distribution facilities, and research laboratories in Japan. It also has a presence across the US, Canada, China, Taiwan, Singapore, Thailand, Malaysia and Vietnam. The company is headquartered in Chuo-Ku, Osaka, Japan.

Scope
  • Detailed information on Sumitomo Pharma Co., Ltd. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Sumitomo Pharma Co., Ltd. in the form of a SWOT analysis
  • An in-depth view of the business model of Sumitomo Pharma Co., Ltd. including a breakdown and examination of key business segments
  • Intelligence on Sumitomo Pharma Co., Ltd.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Sumitomo Pharma Co., Ltd., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
  • Gain understanding of Sumitomo Pharma Co., Ltd. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Sumitomo Pharma Co., Ltd. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Sumitomo Pharma Co., Ltd.'s business structure, strategy and prospects.

Table of Contents

44 Pages
Company Snapshot
Sumitomo Pharma Co., Ltd.: Company Overview
Sumitomo Pharma Co., Ltd.: Overview and Key Facts
Sumitomo Pharma Co., Ltd.: Overview
Sumitomo Pharma Co., Ltd.: Key Facts
Sumitomo Pharma Co., Ltd.: Key Employees
Sumitomo Pharma Co., Ltd.: Key Employee Biographies
Sumitomo Pharma Co., Ltd.: Major Products and Services
Sumitomo Pharma Co., Ltd.: Management Statement
Sumitomo Pharma Co., Ltd.: Locations and Subsidiaries
Sumitomo Pharma Co., Ltd.: Key Competitors
Sumitomo Pharma Co., Ltd.: Company Analysis
Sumitomo Pharma Co., Ltd.: Business Description
Sumitomo Pharma Co., Ltd.: SWOT Analysis
Sumitomo Pharma Co., Ltd.: SWOT Overview
Sumitomo Pharma Co., Ltd.: Strengths
Sumitomo Pharma Co., Ltd.: Weaknesses
Sumitomo Pharma Co., Ltd.: Opportunities
Sumitomo Pharma Co., Ltd.: Threats
Sumitomo Pharma Co., Ltd.: Corporate Financial Deals Activity
Sumitomo Pharma Co., Ltd.: Financial Deals Overview
Sumitomo Pharma Co., Ltd.: Targets and Partners
Sumitomo Pharma Co., Ltd.: Top Deals 2021 - 2025YTD*
Sumitomo Pharma Co., Ltd.: Advisors
Sumitomo Pharma Co., Ltd.: Top Legal Advisors
Sumitomo Pharma Co., Ltd.: Mergers and Acquisitions
Sumitomo Pharma Co., Ltd.: Partnership
Sumitomo Pharma Co., Ltd.: Divestments
Sumitomo Pharma Co., Ltd.: Recent Developments
Sumitomo Pharma Co., Ltd.: News and Events Summary
Sumitomo Pharma Co., Ltd.: Business Reorganization
Sumitomo Pharma Co., Ltd.: Corporate Governance
Sumitomo Pharma Co., Ltd.: Corporate Social Responsibility
Sumitomo Pharma Co., Ltd.: Financial Deals
Sumitomo Pharma Co., Ltd.: Market Developments
Sumitomo Pharma Co., Ltd.: Red Flags/DistressSignals
Sumitomo Pharma Co., Ltd.: Research & Development
Sumitomo Pharma Co., Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Sumitomo Pharma Co., Ltd.: Key Facts
Table 2: Sumitomo Pharma Co., Ltd.: Key Employees
Table 3: Sumitomo Pharma Co., Ltd.: Locations and Subsidiaries
Table 4: Sumitomo Pharma Co., Ltd.: Key Competitors
Table 5: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Table 7: Sumitomo Pharma Co., Ltd.: M&A Average Deal Size - Value (US$m)
Table 8: Sumitomo Pharma Co., Ltd.: Targets and Partners
Table 9: Sumitomo Pharma Co., Ltd.: Top Deals 2021 - 2025YTD*
Table 10: Sumitomo Pharma Co., Ltd.: Legal Advisor Ranking by Value (US$m)
Table 11: Sumitomo Pharma Co., Ltd.: M&A Volume and Value Trend (2021 - YTD*2025)
Table 12: Sumitomo Pharma Co., Ltd.: M&A Activity by Geography (2021 - YTD*2025)
Table 13: Sumitomo Pharma Co., Ltd.: Partnership Volume and Value Trend (2021 - YTD*2025)
Table 14: Sumitomo Pharma Co., Ltd.: Partnership Trend by Deal Type (2021 - YTD*2025)
Table 15: Sumitomo Pharma Co., Ltd.: Divestments Volume and Value Trend (2021 - YTD*2025)
Table 16: Sumitomo Pharma Co., Ltd.: Divestments by Geography (2021 - YTD*2025)
Table 17: Sumitomo Pharma Co., Ltd.: News and Events Summary
Table 18: Sumitomo Pharma Co., Ltd.: Business Reorganization
Table 19: Sumitomo Pharma Co., Ltd.: Corporate Governance
Table 20: Sumitomo Pharma Co., Ltd.: Corporate Social Responsibility
Table 21: Sumitomo Pharma Co., Ltd.: Financial Deals
Table 22: Sumitomo Pharma Co., Ltd.: Market Developments
Table 23: Sumitomo Pharma Co., Ltd.: Red Flags/DistressSignals
Table 24: Sumitomo Pharma Co., Ltd.: Research & Development
Table 25: Sumitomo Pharma Co., Ltd.: Strategy and Operations
List of Figures
Figure 1: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Figure 3: Sumitomo Pharma Co., Ltd.: M&A Average Deal Size - Value (US$m)
Figure 4: Sumitomo Pharma Co., Ltd.: M&A Volume and Value Trend (2021 - YTD*2025)
Figure 5: Sumitomo Pharma Co., Ltd.: M&A Activity by Geography (2021 - YTD*2025)
Figure 6: Sumitomo Pharma Co., Ltd.: Partnership Volume and Value Trend (2021 - YTD*2025)
Figure 7: Sumitomo Pharma Co., Ltd.: Partnership Trend by Deal Type (2021 - YTD*2025)
Figure 8: Sumitomo Pharma Co., Ltd.: Divestments Volume and Value Trend (2021 - YTD*2025)
Figure 9: Sumitomo Pharma Co., Ltd.: Divestments by Geography (2021 - YTD*2025)

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.